Isodiol International Inc. ISOLF

Company Overview

Isodiol International Inc. (OTC: ISOLF) is a Canadian cannabis and hemp-derived wellness company that historically focused on the development, marketing, and distribution of cannabidiol (CBD) consumer products and related pharmaceutical-grade ingredients. The company operated within the broader cannabis, nutraceutical, and health and wellness industries, with product categories that included CBD tinctures, topicals, isolates, and hemp-derived consumer formulations. Public disclosures and historical investor materials indicate that the company positioned itself around vertically integrated cannabinoid sourcing and international distribution capabilities.

The company’s business model was primarily driven by sales of hemp-derived CBD products and intellectual property related to cannabinoid formulations and processing technologies. Isodiol pursued growth through acquisitions, licensing arrangements, and international expansion initiatives during the peak growth period of the global cannabis sector between 2017 and 2019. The company evolved from an early-stage cannabis wellness platform into a multi-brand operator with interests spanning consumer wellness, pharmaceutical applications, and industrial hemp derivatives. However, publicly available information regarding current operating scale and active commercial operations has been limited in recent years, and some operational data is inconclusive based on available public sources.